Journal
NUCLEIC ACIDS RESEARCH
Volume 35, Issue 12, Pages 4186-4194Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkm438
Keywords
-
Categories
Funding
- NIGMS NIH HHS [R01 GM059159, GM59159] Funding Source: Medline
Ask authors/readers for more resources
Here we report in vitro selection of a novel ribozyme that catalyzes the 5 '-nucleotidyl transfer reaction forming the 2 '-5 ' phosphodiester bond. This ribozyme was retrieved as a sole sequence in the pool enriched for the 5 '-triphosphate-dependent activities in incorporating ATP-gamma S. The originally selected ribozyme consisting of 109-nucleotide (nt) was miniaturized to 45-nt M4 ribozyme via a series of mutation studies, and based on this mini-ribozyme a trans-acting system was constructed. One of the most challenging tasks in our study was to determine the chemistry occurring at the 5 '-ppp site. We utilized various analytical methods including MALDI-TOF analysis of the product generated by the trans-acting system and elucidated the chemistry to be 3 '-> 5 ' mononucleotide extension forming the 2 '->-5 ' phosphodiester bond. Interestingly, M4 ribozyme promiscuously accepts a variety of purine nucleotides bearing 5 '-mono-, di- and triphosphates as substrates. This remarkable ability of M4 ribozyme would lead us to the development of a new tool for the 5 '-modification of RNAs with unique chemical groups.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available